The two organizations will partner on content including personal stories and expert advice.
Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).
Not only isn't print dead, as ahead-of-themselves media wonks have claimed for the past decade, but it's thriving in a most unlikely environment: the point of care
Facebook's decision to reprioritise its news feed to favour "social interactions" over other forms of content may please its users but will be challenging for brands.
The agency issue, people moves, and a series of restructures top the list.
The digital health startup was founded in 2015.
GroupM, the media investment arm of WPP, forecasts global ad growth of 4.3% in 2018, and predicts Google and Facebook will strengthen their stranglehold on digital advertising.
WebMD reportedly lays off 10% of workforce; Roche blocks Herceptin biosimilar with patent suit; insurers cover Collegium's Xtampza over Purdue's OxyContin
Emmy-nominated Maia Samuel becomes executive director of expanded Haymarket Content Lab; Bernadette Casey promoted to executive director of Haymarket Content Hub.
Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.
Why is revenue growth at some of the agency groups lagging forecasts for global ad expenditure?
Condé Nast, Time Inc., and Vice Media have all recently launched health content businesses.
The goal is to further cement point of care as a mainstream media channel.
In a follow-up to last year's media report, the Association of National Advertisers details "dysfunction" and rigged bids.
The deal is worth roughly $2.8 billion.
Amgen and Teva raise prices of leukemia drugs twice this year; Roche acquires diabetes app; docs use Snapchat to share patient scans
In apportioning their media budgets, pharma companies continue to straddle the line between new and traditional strategies.
This and other changes in the market have created demand for new offerings, like mobile-friendly sites, video, and patient communities.
Bayer, Eli Lilly, GlaxoSmithKline, and Sanofi have suspended advertising on the show, according to news reports.
Healthcare is sometimes about life or death, but is almost always about quality of life, says the EVP of health system products and strategy.
WPP creates WPP Health & Wellness; Publicis Health formalizes new name; 10 ways healthcare companies are testing Instagram
Drugmakers are becoming much more cautious with their budgets, WebMD executives said.
The company acquired Everyday Health in December.
Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation
The search-engine giant says that one in 20 online searches are related to healthcare, and more users are using mobile to consume media.
How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy
J&J in talks to buy Actelion; Novo Nordisk pulls ads on Breitbart News; Takeda to market Ninlaro in Europe
Drugmakers can do a better job of organizing dosing information, safety information, and clinical data on their brand websites, a new survey found.
Merck Consumer Health CMO Atilla Cansun also talks about about why the company is focused on preparing society for an average lifespan of 100 years.
GlaxoSmithKline's campaign goal was to educate grandparents (particularly first-time grandparents) and parents about the serious nature of whooping cough.